Sulforaphane for Skin Aging
Trial Summary
What is the purpose of this trial?
This trial involves applying sulforaphane, a compound from vegetables, to the skin of participants. The study aims to see if sulforaphane can change how the skin ages and responds to light by looking at specific skin proteins. Participants will have both sun-exposed and non-exposed skin areas treated and monitored over time.
Will I have to stop taking my current medications?
The trial requires that you stop using systemic retinoids or steroids for at least a month and topical steroids, retinoids, or other topical drugs for at least two weeks before joining the study.
What evidence supports the effectiveness of the treatment Sulforaphane for skin aging?
Research shows that sulforaphane, found in broccoli, can help protect the skin from aging by boosting antioxidant activity and collagen production, which are important for maintaining skin health. Studies in mice and human skin models suggest that sulforaphane can reduce skin damage from UV light and improve skin appearance by activating protective pathways in the body.12345
Is sulforaphane safe for human use?
How does the treatment sulforaphane differ from other treatments for skin aging?
Sulforaphane is unique because it activates the Nrf2 pathway, which helps control inflammation and oxidative stress, key factors in skin aging. Unlike many treatments, it is derived from natural sources like broccoli and works by enhancing the skin's antioxidant capacity and collagen production, offering a novel approach to combating skin aging.12369
Research Team
Anna Chien
Principal Investigator
Department of Dermatology, Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for adults over 18 with healthy skin or moderate photoaging, who can undergo a skin biopsy and light exposure. They must understand the study and agree to follow its rules. People with recent drug trials, broccoli allergies, steroid or retinoid treatments, bleeding disorders, excessive scarring tendencies, pregnancy/nursing status, anesthesia allergies or significant medical issues are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants apply topical sulforaphane for up to 6 months, with up to 8 study visits including photography, clinical assessment, UV light irradiation, visible light treatment, skin biopsies, and non-invasive elasticity measurements
Follow-up
Participants are monitored for changes in keratin expression and skin response after treatment
Treatment Details
Interventions
- Sulforaphane
- UV or visible light
Sulforaphane is already approved in United States for the following indications:
- None approved; used in clinical trials for various conditions including chronic kidney disease and prevention of age-associated cardiac and vascular dysfunction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor